1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → Dibenzofuran-2-carboxylic acid {2-oxo-2-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethyl}-amide

HRID 1177881

Reaktionsgleichung

Reaktionsgleichung von HRID 1177881
CCN(C(C)C)C(C)C.[CH:10]1[C:18]2[C:17]3[CH:19]=[CH:20][CH:21]=[CH:22][C:16]=3[O:15][C:14]=2[CH:13]=[CH:12][C:11]=1[C:23]([OH:25])=O.C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.FC(F)(F)C(O)=O.[NH2:54][CH2:55][C:56]([N:58]1[CH2:63][CH2:62][N:61]([C:64](=[O:75])[C:65]2[CH:70]=[CH:69][CH:68]=[CH:67][C:66]=2[C:71]([F:74])([F:73])[F:72])[CH2:60][CH2:59]1)=[O:57]>CN(C=O)C.O>[O:57]=[C:56]([N:58]1[CH2:59][CH2:60][N:61]([C:64](=[O:75])[C:65]2[CH:70]=[CH:69][CH:68]=[CH:67][C:66]=2[C:71]([F:74])([F:73])[F:72])[CH2:62][CH2:63]1)[CH2:55][NH:54][C:23]([C:11]1[CH:12]=[CH:13][C:14]2[O:15][C:16]3[CH:22]=[CH:21][CH:20]=[CH:19][C:17]=3[C:18]=2[CH:10]=1)=[O:25]

Komponenten

8

Edukt 5

HCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 4174048-Oxatricyclo(7.4.0.0,2,7)trideca-1(9),2(7),3,5,10,12-hexaene-4-carboxylic acidHCID 866340882-amino-1-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethanone TFA salt

Produkt 1

HCID 59559637Dibenzofuran-2-carboxylic acid {2-oxo-2-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethyl}-amideAusbeute 33,6 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 962WaterLösungsmittelHCID 6228DimethylformamideLösungsmittel

Versuchsvorschrift

DIPEA (137 mg, 0.18 mL, 1.06 mmol) was added to a stirred solution of dibenzofuran-2-carboxylic acid (75 mg, 0.35 mmol) in DMF (3 mL). HOBT (47.8 mg, 0.35 mmol) and EDCI (81.3 mg, 0.42 mmol) were then added at room temperature. After 2 minutes 2-amino-1-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethanone trifluoroacetic acid salt (166 mg, 0.38 mmol) was added and the resulting mixture was stirred at room temperature overnight. Cold water was then added, filtered the solid precipitated to afford 60 mg (33.3%) of dibenzofuran-2-carboxylic acid {2-oxo-2-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethyl}-amide. LCMS Purity: 97.09%. 1H NMR (DMSO-d6): δ 8.7 (bs, 2H), 8.2 (d, 1H), 8.06 (d, 1H), 7.9-7.55 (m, 7H), 7.55 (t, 1H), 4.41-4.3 (bs, 2H), 3.8-3.6 (bs, 4H), 3.5-3.4 (bs, 2H), 3.2-3.0 (bs, 2H).

Aufarbeitung

  1. filtrationfiltered the solid
  2. customprecipitated

Quellen und Nachweise

ORD-Eintrag
ord-da3c82b78e184cd6859a7284c71df3ff
Quelldatensatz
uspto-grants-2010_11
Patentnummer
US07842696B2

Verknüpfte Notizen

Wird geladen…